SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES for SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Outreach and monitoring related to the tobacco industry. Outreach and monitoring related to federal COVID-19 relief and stimulus legislation. Outreach and monitoring related to FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, and tobacco product user fees. Monitored the following: H.R. 133, FY 2021 Omnibus and COVID Relief and Response Act. H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019. S. 1253 / H.R. 3942, Preventing Online Sales of E-Cigarettes to Children Act. Monitored the following: -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOE AUGUSTUS | — |
| CHRIS HOWARD | — |
| CHRISTINE HEWITT LANZA | — |
| MICHAEL MORROW | — |
| DANIEL TROPE | — |
Tobacco TOB
Outreach and monitoring related to the tobacco industry. Outreach and monitoring related to federal COVID-19 relief and stimulus legislation. Outreach and monitoring related to FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, and tobacco product user fees. Monitored the following: H.R. 133, FY 2021 Omnibus and COVID Relief and Response Act. H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019. S. 1253 / H.R. 3942, Preventing Online Sales of E-Cigarettes to Children Act. Monitored the following: -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOE AUGUSTUS | — |
| CHRIS HOWARD | — |
| CHRISTINE HEWITT LANZA | — |
| MICHAEL MORROW | — |
| DANIEL TROPE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.